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Abstract
Altered gravity is known to affect cellular function by changes in gene expression and cellular signaling. The intracellular
signaling molecule cyclic guanosine-3′,5′-monophosphate (cGMP), a product of guanylyl cyclases (GC), e.g., the nitric
oxide (NO)-sensitive soluble GC (sGC) or natriuretic peptide-activated GC (GC-A/GC-B), is involved in melanocyte
response to environmental stress. NO-sGC-cGMP signaling is operational in human melanocytes and non-metastatic
melanoma cells, whereas up-regulated expression of GC-A/GC-B and inducible NO synthase (iNOS) are found in metastatic
melanoma cells, the deadliest skin cancer. Here, we investigated the effects of altered gravity on the mRNA expression
of NOS isoforms, sGC, GC-A/GC-B and multidrug resistance-associated proteins 4/5 (MRP4/MRP5) as selective cGMP
exporters in human melanoma cells with different metastatic potential and pigmentation. A specific centrifuge (DLR,
Cologne Germany) was used to generate hypergravity (5 g for 24 h) and a fast-rotating 2-D clinostat (60 rpm) to simulate
microgravity values ≤0.012 g for 24 h. The results demonstrate that hypergravity up-regulates the endothelial NOS-sGC-
MRP4/MRP5 pathway in non-metastatic melanoma cells, but down-regulates it in simulated microgravity when compared
to 1 g. Additionally, the suppression of sGC expression and activity has been suggested to correlate inversely to tumor
aggressiveness. Finally, hypergravity is ineffective in highly metastatic melanoma cells, whereas simulated microgravity
down-regulates predominantly the expression of the cancer-related genes iNOS and GC-A/GC-B (shown additionally on
protein levels) as well as motility in comparison to 1 g. The results suggest that future studies in real microgravity can benefit
from considering GC-cGMP signaling as possible factor for melanocyte transformation.
Keywords Guanylyl cyclase-cGMP signaling · Human melanoma cells · Hypergravity · Simulated microgravity ·
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Introduction
Gravity (g) alterations are known to affect gene expression
and cellular functions. Both, the condition of microgravity
that means without the impact of the gravitational stimulus
as well as hypergravity, which means increase of the grav-
itational stimulus to a moderate physiological level, have
been proven as tools to elucidate the effects of gravity on
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cellular response (Aleshcheva et al. 2016; Brungs et al.
2016; Hughes-Fulford and Lewis 1996; Hughes-Fulford
2003; Ivanova et al. 2004, 2011; Ulbrich et al. 2011; Thiel
et al. 2012). To our knowledge, studies concerning the influ-
ence of gravity on human melanocytes and melanoma cells
in respect to activation and cellular responses that are impor-
tant for malignant transformation have been rarely reported.
As specialized skin cells, human epidermal melanocytes
provide protection against harmful ultraviolet (UV) radi-
ation and oxidative stress by generating the radical scav-
enging pigment melanin. Melanocytes are also precursor
cells of melanoma, the deadliest skin cancer. Although
exposure to UV radiation (UVA and UVB) is a major
risk factor for melanoma development, it can also arise
on not UV-exposed skin, depending on inflammation and
immune status (Merkel and Gerami 2017; Sample and He
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2017). In addition, space flight induces a reduction in the
immune competence among crew, leading to increased risk
of infection and altered antibiotic susceptibility (Ullrich
et al. 2008; Taylor 2015; Frippiat et al. 2016). Interestingly,
reduced cyclic guanosine-3′,5′-monophosphate (cGMP or
cyclic GMP) levels in human plasma were found in astro-
nauts after long-term space flight (Rossler et al. 2001).
Cyclic GMP is an intracellular signaling molecule that
regulates essential (patho)physiologigal processes in multi-
ple cell types including tumor cells, such as smooth mus-
cle relaxation, platelet aggregation, neurotransmission, cell
growth and survival (Lucas et al. 2000; Beavo and Brun-
ton 2002; Bian et al. 2012; Fajardo et al. 2014). It can be
generated from GTP by two classes of guanylyl cyclases
(GC), the nitric oxide (NO)-sensitive soluble GC (sGC)
(Derbyshire and Marletta 2012) or the peptide-activated
membrane-bound GC, such as the atrial natriuretic peptide
(ANP)-responsive GC-A or the C-type natriuretic peptide
(CNP)-responsible GC-B (Potter et al. 2006). The sGC
occurs as a heme-containing heterodimeric protein con-
sisting of α and β subunits (Gerzer et al. 1981; Ignarro
1990). The α1β1 heterodimer is the predominant sGC iso-
form that is required for catalytic activity (Zhao et al.
1998). Cyclic GMP exerts its effects by targeting down-
stream effectors such as cGMP-dependent protein kinases
(PKG), cGMP-regulated phosphodiesterases (PDE), cyclic
nucleotide-gated channels, and the multidrug resistance-
associated proteins 4 (MRP4) and 5 (MRP5) as selective
cGMP exporters (Wielinga et al. 2003; Hofmann 2005;
Conti and Beavo 2007; Biel and Michalakis 2009). In addi-
tion, whereas MRP5 has much higher affinity to export
cGMP than MRP4 (Sager 2004; Jedlitschky et al. 2000;
Wielinga et al. 2003), both MRP4 and MRP5 also export
nucleoside analogs that are used in antiviral and anticancer
therapy (Deeley et al. 2006).
For melanocytes, the NO-sGC-cGMP-PKG signaling
pathway is involved in UV-B-dependent melanogenesis
(Romero-Graillet et al. 1996) as well as in NO-induced
detachment from extracellular matrix components like
fibronectin (Ivanova et al. 1997, 2005). Importantly, the
NO-sGC-cGMP signaling in association with pigmentation
is operational in human melanocytes and non-metastatic
melanoma cells and not in highly metastatic phenotype
(Ivanova et al. 2001, 2008). On the contrary, expression
and activities of the ANP-responsible GC-A and CNP-
responsible GC-B in human metastatic melanoma cells
were related to their metastatic potential (Ivanova et al.
2001, 2008). Further, it was shown that GC-A attenuation
or deficiency protects mice from tumorigenesis in lung
and ovarian cancer as well as in melanomas, possibly
because GC-A positive cells in the tumor stroma are
involved in the regulation of local inflammation and tumor
angiogenesis (Kong et al. 2008). It has also been reported
that CNP promotes melanoma cell growth and migration
via activation of the GC-B-cGMP-PKGI pathway (Dhayade
et al. 2016). In addition, expression of the inducible NOS
(iNOS) predicts poor survival for stage III melanoma
patients and low levels of NO production by constitutive
iNOS expression seem to play a role in the melanoma
resistance to apoptosis (Ekmekcioglu et al. 2006; Grimm
et al. 2008).
Finally, the cGMP signaling is also involved in
melanocyte response to gravity alterations. Hypergravity
(up to 5 g for 24 h) stimulated cGMP efflux in cultured
human melanocytes and non-metastatic melanoma cell lines
and not in metastatic phenotypes under conditions of lim-
ited PDE activities or increased sGC activity via stimulation
by NO, whereas simulated microgravity (≤0.012 g for 24 h)
down-regulated the expression of the natriuretic peptide-
responsible GC-A and GC-B in human melanoma cells
(Ivanova et al. 2004, 2011; Stieber et al. 2005).
In the present study, we focused on the effects of
altered gravity on the expression of GC-cGMP signaling
components (e.g., iNOS/eNOS, sGC, GC-A/GC-B, PKGI,
PDE5, MRP4/MRP5, and tyrosinase—TYR as a key
enzyme in melanogenesis) in melanoma cell lines with
different metastatic potential and pigmentation. A specific
centrifuge (STATEX II, DLR, Cologne Germany) that
allows defined acceleration changes (Neubert et al. 1996)
was used to generate hypergravity in a physiological
range and a fast rotating 2-D clinostat with a horizontal
axis of rotation (Briegleb 1992) to simulate microgravity
conditions (Herranz et al. 2013). Our study demonstrates
that simulated microgravity down-regulates the expression
cancer-related cGMP-signaling components as well as
motility in highly metastatic melanoma cells.
Materials andMethods
Cell Culture and Transfection Procedure
The human melanoma cell lines used in this study were
a kind gift from Prof. Dr. G. van Muijen, Department
of Pathology, Nijmegen University, The Netherlands.
Pigmented 1F6 -non-metastatic (Danen et al. 1993) to low
metastatic (Le Poole et al. 1997) and highly metastatic
and non-pigmented BLM melanoma cells (Van Muijen
et al. 1991; Danen et al. 1993) were grown in Dulbecco’s
modified Eagle’s medium (DMEM), supplemented with
10% (v/v) heat-inactivated fetal calf serum (FCS), 2 mM
glutamine, and antibiotics (all from Invitrogen, Thermo
Fisher Scientific GmbH, Langenselbold, Germany) as
described elsewhere (Ivanova et al. 1997).
The 1F6 melanoma cell line (functional sGC expression)
was transfected with siRNA for sGC-β1 subunits using the
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ON-TARGETplus™ SMARTpool siRNA reagents (Fischer
Scientific Dharmacon, Langesebold, Germany) according
to the manufacture’s protocol. Briefly, the melanoma cells
were seeded at a density of 0.2 × 106 cells per 12.5 cm2
flasks or 0.10 × 106 cells per 9 cm2 slide flasks and were
then cultivated for 24 h in antibiotic-free complete DMEM
medium at 37 ◦C, 5% CO2. After washing with phosphate
buffered saline (PBS), the cells were transfected with
100 nM siRNA-sGCβ1 (SMARTpool I, J006733050020,
UCAUGAACCUGGACGAUUU), 50 nM siRNA-PPIB
(positive control) (D00182010), 50 nM non-targeting or
scrambled siRNA as negative control (SMARTpool I,
D0018100120), and 6 μl DharmaFECT 1 transfection
reagent (T200103) (all from Abgene Ltd., Cambridge,
UK) in 2 ml DMEM medium supplemented with 0.2%
FCS. The target mRNA knockdown was assayed after
24 h of transfection. The inhibition with siRNA-sGC-β1
was measured by both quantitative real-time polymerase
chain reaction (qPCR) and Western blot analyzes.
Experimental Design
For exposure to altered gravity conditions, human melanoma
cells were seeded at a density of 0.2×106/0.4×106 (BLM)
or 0.4 × 106/0.8 × 106 (1F6) cells per 12.5 cm2/24 cm2
culture flasks (Falcon, Becton & Dickinson, Heidelberg,
Germany) for hypergravity and of 0.1 × 106 (BLM) or
0.2 × 106 (1F6) cells per 9 cm2 slide flasks (Nunc, Thermo
Fisher Scientific, Langenselbold, Germany) for simulated
microgravity experiments, respectively. Cells were then
grown for 24 h at 37 ◦C and 5% CO2 in DMEM, containing
10% FCS and antibiotics. After washing with PBS, the cells
were maintained for 3 h at 37 ◦C and 5% CO2 in culture
flasks completely filled with mitogen-deficient medium,
containing phenol-red free DMEM medium supplemented
with 0.25% bovine serum albumin (BSA), 10 mM
HEPES (4-(2-hydroxyethyl)-1-piperazine-ethanesulphonic
acid), pH 7.4 (DMEM-HEPES) (Sigma-Aldrich Chemie
GmbH, Munich, Germany) and 0.1 mM 3-isobutyl-1-
methylxanthine (IBMX) (Sigma-Aldrich Chemie GmbH,
Munich, Germany) as a non-selective PDE inhibitor.
Finally, the different experiments were performed only
with cells from the same passage number. Cell viability
was assessed by trypan blue exclusion assay and cell
morphology was monitored by light microscopy.
Hypergravity was produced by centrifugation with a
STATEX II centrifuge from the Spacelab mission D2 (DLR,
Cologne, Germany) (Neubert et al. 1996) modified for
studies with cell cultures as described previously (Ivanova
et al. 2004). Briefly, the flasks positions were adjusted
to be perpendicular to the acceleration vector that is the
resultant vector of both the centrifugal vector and the normal
(Earth’s) gravity vector. Constant hypergravity levels (up
to 10 g) were achieved by selecting the rotor speed at
the appropriate rotations per minute (rpm) and adjusting
the respective angle of the culture flask position to the
centrifuge bottom. Consequently, constant levels of 5 g
were attained by placement of 8–10 culture flasks (12 cm2–
24 cm2) in a rotor of the centrifuge at fixed distances of
13.5 cm from the center of rotation with a flask position
to the centrifuge bottom of 78.5◦ and a rotor speed of
180 rpm. All centrifugation experiments were performed
in a temperature-controlled room (37 ◦C) in closed culture
flasks saturated with 5% CO2. In a previous report we
demonstrated that exposure to hypergravity (2 g and 5 g,
but not 9 g) for 12 h and 24 h induced alterations in cGMP
levels in 1F6 melanoma cells with a maximal effect at 5 g
for 24 h (Ivanova et al. 2004). In addition, exposure of
cells to hypergravity for longer period than 24 h reduced
the cell viability considerable. Consequently, results of
changes in the expression of genes involved in cGMP
signaling upon application of 5 g for 24 h are presented. In
simultaneously performed 1-g control experiments, flasks
with adherent melanoma cells were placed in a horizontal
position (180◦) near the centrifuge for the same period of
time. For subsequent analysis cells from the whole flasks
were harvested.
For simulated microgravity experiments, a fast-rotating
2-D clinostat (DLR, Cologne, Germany) was used, which
was originally developed by Briegleb and modified by
Hauslage (DLR, Cologne Germany) for the use of
commercially available slide flasks (Briegleb 1992; Ivanova
et al. 2011; Eiermann et al. 2013). Briefly, the modified
fast-rotating 2-D clinostat provides two parallel horizontal
rotating axes, each with adapters for fixation of the slide
culture flasks. In addition, the rotation of the sample around
one axis is perpendicular to the direction of the gravity
vector. For each experiment, 3 slide culture flasks (9 cm2)
were inserted per rotation axis of the clinostat, which
was placed in a temperature-controlled room (37 ◦C). As
clinorotation generates centrifugal forces, which depends
on the cell’s distance from the rotation axis and the
rotation speed, we used an appropriate slide chamber for
harvesting of adherent cells exposed to defined maximal
residual accelerations (Eiermann et al. 2013). In addition,
we previously reported a maximal reduction of the GC-A
mRNA levels in the investigated melanoma cells after an
exposure to residual accelerations of ≤0.012 g for 24 h
compared to 1-g control cells (Ivanova et al. 2011; Eiermann
et al. 2013). Therefore, clinorotation for 24 h at 37 ◦C
with a rotor speed of 60 rpm was used in the following
experiments. Using slide chambers, only cells inside an area
of 6 mm diameter in the rotation axis (g-forces ≤0.012 g)
were harvested for mRNA and protein analyzes. For all
experiments, 1-g controls were prepared simultaneously and
placed inside the clinostat box in a horizontal position.
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RNA Isolation and Real-Time Quantitative
Polymerase Chain Reaction (qPCR) Analyzes
Total RNA from melanoma cells was isolated using the
RNeasy Plus Micro kit (Qiagen, Hilden, Germany) fol-
lowing the manufacturer’s suggestions. Briefly, reverse
transcription of 1 μg of total RNAwas performed using ran-
dom priming (QuantiTect Reverse Transcription system,
Qiagen, Hilden, Germany). The resultant single-stranded
cDNA was subjected to qPCR using QantiTect primer
assays or RT2 qPCR Primer assays (Quiagen, Hilden,
Germany) for GC-A (QT00081963), GC-B QT00013727),
sGC-α1 (QT01001840), sGC-β1 (QT00080815), eNOS
(PPH01298E), iNOS (PPH00173E), PKGI (QT00001638),
PDE5A (QT00048167), TYR (QT00080815), MRP4
(QT00077266), MRP5 (QT00049959), internal controls:
glyceraldehyde 3-phosphate dehydrogenase (GAPDH:
QT00079247), β-actin (QT1680476), hypoxanthine
phosphoribosyltransferase 1 (HPRT1: QT00059066), or
Cyclophiline B (PPIB: QT00067186), and SYBR green as a
fluorescent dye (QuantiFast SYBR Green PCR kit,
Qiagen). No-template (water) reaction mixtures were
additionally prepared as negative controls. All reactions
were conducted using a LightCycler 1.5 Detector System
(Roche, Mannheim, Germany). The conditions for the real-
time PCR assay were 5 min at 95 ◦C, 35–40 cycles at 94 ◦C
for 15 s, 60 ◦C for 30 s, and 72 ◦C for 20 s, following 65 ◦C
for 15 s and 40 ◦C for 30 s. The gene expression levels were
calculated using the calibrator-normalized and efficiency-
corrected relative quantification method (RelQuant
Software, LightCycler, Roche). We used as calibrator
1F6 melanoma cells, which were cultivated in DMEM,
containing 10% FCS. Briefly, the expression level of each
gene in the samples as well as of the calibrator were first
normalized to the HPRT1 (Ct= CT targetgene− CtHPRT1)
and then expressed as the target gene/reference gene ratio
of each sample normalized by the target gene/reference
gene ratio of the calibrator.
Western Blot Analysis
For fractionated extraction of the cytosolic and mem-
brane proteins in the investigated melanoma cells, a cell
fractionation kit with different extraction buffers (mem-
brane: CF-MEM and cytosolic: CF-CYT) containing phos-
phatase inhibitors was applied according to the manufac-
turer instructions (NanoTools, Teningen, Germany). Briefly,
the buffers were supplemented with protease inhibitors
using cOmplete ultra protease inhibitors cocktail tablets
(Roche, Mannheim, Germany). After exposure to altered
gravity, melanoma cells and control cells including trans-
fected with siRNA for sGC-β1 subunits 1F6 melanoma cells
were harvested. The collected cell pellets were then resus-
pended with ice cold CF-CYT extraction buffer and incu-
bated for 5 min at room temperature (RT). The cytosolic
fractions were collected by centrifugation for 5 min at
1000× g at 4 ◦C. The pellets were washed, incubated with
CF-MEM extraction buffer for 5 min at RT, and the mem-
brane fraction was isolated by centrifugation for 5 min at
2000× g. Protein concentrations of the samples were ana-
lyzed using the BCA protein assay Kit (Pierce, Thermo
Fisher Scientific, Langenselbold, Germany).
Aliquots of each CF-MEM buffer or CF-CYT (each
20 μg protein) were subjected to sodium dodecyl sulfate
polyacrylamide (SDS-PAGE) gels using Mini-PROTEAN
Tetra Cell System (Bio-Rad Laboratories GmbH, Munich,
Germany) and transferred onto nitrocellulose membrane
(0.45 μm, Amersham Hybond ECL Nitrocellulose Mem-
brane, GE Healthcare Europe GmbH, Freiburg, Germany)
in Mini Trans-Blot Cell System (Bio-Rad Laboratories
GmbH, Munich, Germany). Membranes were washed in
Tris-buffered saline (20 mM Tris, 150 mM NaCl, pH
7.3) containing 0.1% Tween20 (TBST) and were blocked
overnight at 4 ◦C (GC-B, sGC-β1, and iNOS) or 90 min
at RT (GC-A) in TBST, containing 5% fat-free dry milk
and 0.3% BSA. The membranes were then incubated with
specific primary rabbit polyclonal antibodies: anti-sGC-β1
(sc-20955, H-79, 65 kDa) and anti-GC-B (sc-25486, H-80,
120 kDa); with monoclonal (mousse) antibodies: anti-GC-A
(sc-137041, H-80, 120 kDa) and anti-iNOS (sc-7271, C-11,
131 kDa) (all in 1:100 dilution), or anti-β-actin (sc-47778,
C-4, 43 kDa, 1:2500 dilution) for 90 min at RT (GC-B,
sGC-β1 and iNOS) or overnight at 4 ◦C (GC-A). All pri-
mary antibodies were diluted in TBST. After extensively
washing with TBST, membranes were incubated with sec-
ondary goat-anti-rabbit horseradish peroxidase (HRP) con-
jugated IgG (sc-2030), diluted in TBST (sGC-β1 and GC-B,
1:2000) or goat-anti-mouse IgG-HRP (sc-2005), diluted in
TBST (iNOS, 1:2000; β-actin, 1:5000) for 60 min at RT.
All antibodies were purchased from Santa Cruz Biotech-
nology Inc. (Heidelberg, Germany). The proteins were
visualized by enhanced chemiluminescence (ECL) using
ImmunoCruz™western blotting luminol reagent (sc-2048,
Santa Cruz) and the ECL Detector system (ChemiDoc™
XRS+ System, Bio-Rad, Munich, Germany).
Scratch Assay
Highly metastatic BLM melanoma cells (0.2 × 106) were
seeded into 9 cm2 slide culture flasks and incubated as
described in the Experimental Design Section. A scratch
wound on each confluent monolayer of human BLM
melanoma cells was made along the rotation axis using a
sterilized 200 μl-tip (diameter of 600 μm). After washing
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with PBS, the cells were maintained for 2 h at 37 ◦C and
5% CO2 in culture flasks completely filled with mitogen-
deficient and phenol-red free DMEM-HEPES buffer. For
subsequent analysis, the group of the 1-g control cell
monolayers (0 h, 6 h, 12 h and 24 h after scratching) as well
as the group of the clinorotated cell monolayers (6 h, 12 h
and 24 h after scratching) were washed gently with PBS.
Then, the slides were disconnected from the slide flasks and
the cells were fixed using 4% formaldehyde. Finally, 25–
35 images of each scratch wounded BLM cell monolayer
of the clinorotated slides as well as 25–35 images of each
cell monolayer of the 1-g control slides were captured using
an inverse microscope (Zeiss Axiovert 135) equipped with
CCD-Camera Zeiss MRc5. The images were then analyzed
using Zeiss AxioVison 4.83 software.
Statistics
Data obtained from centrifugation and simulated micrograv-
ity experiments were analyzed using GraphPad Prism 6.05
(GraphPad Software, Inc., La Jolla, CA, USA). The values
were expressed in mean ± SEM. Intergroup comparisons
were performed by unpaired Student‘s t (two-tailed) with
P < 0.05 considered as significant and P < 0.01 as highly
significant, respectively.
Results
Hypergravity Up-Regulates mRNA Expression
of eNOS, sGC-β1, MRP4, MRP5, and Tyrosinase
in Non-metastatic Melanoma Cells
Using a biochemical approach, we have previously shown
that hypergravity (up to 5 g for 24 h) stimulates cGMP
efflux at least partly via MRP4/MRP5-dependent transport
and induces an elevation in the melanin content in cultured
human melanocytes and non-metastatic melanoma cell
lines, expressing NO-sensitive sGC (Ivanova et al. 2004;
Stieber et al. 2005), but not in highly metastatic melanoma
cell lines, which do not express the sGC-β1 subunit
(Ivanova et al. 2004). These observations prompted us
to investigate the effects of hypergravity on the mRNA
expression of genes involved in cGMP signaling (e.g., NOS
isoforms, sGC and GC-A/GC-B) in non-metastatic 1F6
and highly metastatic BLM melanoma cells. In pigmented
1F6 melanoma cells (Fig. 1a), hypergravity (5 g for 24 h)
enhanced predominantly the relative mRNA expression of
eNOS (5 g / 1 g ratio: 1.31 ± 0.01), sGC-β1 (5 g / 1 g ratio:
1.19 ± 0.02), MRP4 (5 g / 1 g ratio: 1.24 ± 0.04) and MRP5
(5 g / 1 g ratio: 1.39 ± 0.02), and TYR (5 g / 1 g ratio: 1.42
± 0.03), a key enzyme in melanin synthesis.
To further study the dependence of hypergravity effects
on the presence of NO-sensitive sGC, we performed hyper-
gravity experiments with 1F6 melanoma cells transfected
with siRNA against the sGC-β1 subunit (Fig. 1b). The
down-regulation of the sGC-β1 expression was revealed by
real-time qPCR (75% ± 4.2%) as well as by Western blot
analysis, respectively (Fig. 1b). Whereas the hypergravity-
induced up-regulation in the mRNA levels of expression
of eNOS, MRP4, and MRP5 in parental cells was fully
reversed in the transfected cells in comparison to 1-g con-
trols, the respective mRNA levels of the TYR were still
detectable (5 g / 1 g ratio: 1.14 ± 0.02) (Fig. 1b). Together,
these results indicate that eNOS-sGC-cGMP-MRP4/MRP5
signaling is up-regulated in non-metastatic melanoma cells
at hypergravity compared to 1 g.
In contrast, hypergravity (5 g for 24 h) did not
significantly alter the GC-A and GC-B mRNA expression
in 1F6 melanoma cells (Fig. 1a) as well as in 1F6 melanoma
cells transfected with siRNA against the sGC-β1 subunit
(Fig. 1b) and in highly metastatic BLM melanoma cells
(Fig. 1c). Finally, the mRNA expression of eNOS and iNOS
are also not affected in centrifuged highly metastatic BLM
melanoma cells compared to 1-g controls (Fig. 1c). Thus,
whereas GC-A/GC-B-cGMP-dependent signaling appears
to be insensitive to increased accelerations in non-metastatic
1F6 and highly metastatic BLM melanoma cells, the
e/iNOS-dependent cGMP signaling remains unchanged
only in highly metastatic BLM melanoma cells.
SimulatedMicrogravity Down-Regulates Expression
of GC-cGMP Signaling Components
Using a fast-rotating 2-D clinostat (60 rpm), we have stud-
ied the effect of simulated microgravity (≤0.012 g for 24
h) on the expression of genes involved in GC-cGMP signal-
ing in human 1F6 and BLM melanoma cells as examples
for melanoma cells expressing different GC isoforms. In our
previous report we showed down-regulation of GC-A and
GC-BmRNA expression in both cell types at simulated micro-
gravity conditions in comparison to 1-g controls (Ivanova
et al. 2011). Here, we demonstrate a reduction in the relative
mRNA expression (≤0.012 g /1 g ratio) of eNOS (0.71 ±
0.04), sGC-β1 (0.76 ± 0.05), MRP4 (0.69 ± 0.07), MRP5
(0.74 ± 0.02), but not in TYRmRNA levels in 1F6melanoma
cells after cell exposure to simulated microgravity (Fig. 2a).
In addition, the relative mRNA values for GC-A (0.55 ±
0.04) and GC-B (0.53 ± 0.03) presented in the figure are
similar to previously published (Ivanova et al. 2011).
In order to studywhether the down-regulation of the expres-
sion of the cGMP signaling components in 1F6 melanoma
cells depends on the presence of NO-sensitive sGC, we
compared the mRNA expression levels of eNOS, iNOS,
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Fig. 1 Hypergravity up-regulates mRNA expression of eNOS-sGC-
MRP4/MRP5 signaling in human melanoma cells expressing func-
tional sGC. a Relative mRNA expression of eNOS/iNOS, sGC-
α1/sGC-β1, GC-A/GC-B, MRP4/MRP5, and TYR in non-metastatic
1F6 melanoma cells. b Relative mRNA expression of eNOS/iNOS,
GC-A/GC-B, MRP4/MRP5, and TYR in 1F6 melanoma cells trans-
fected with siRNA against the sGC-β1 subunit or with scrambled
siRNA. Representative Western blots for detecting the efficiency of
sGC-β1 subunit downregulation in transfected 1F6 melanoma cells in
comparison to control cells (CTR) and of β-actin as a loading con-
trol. c Relative mRNA expression of eNOS/iNOS, GC-A/GC-B, and
MRP4/MRP5 in highly metastatic BLM melanoma cells. All investi-
gated human melanoma cells were exposed to 5 g using the STATEX
II centrifuge or to 1 g for 24 h. The relative mRNA expression (5
g/1 g) of eNOS/iNOS, sGC-α1/sGC-β1, GC-A/GC-B, MRP4/MRP5
and TYR were measured by quantitative real-time PCR analysis using
calibrator-normalized and efficiency-corrected relative quantification
method (LightCycler®, Roche, Mannheim, Germany). Data in bar
graphs (black bars—non-metastatic 1F6 melanoma cells; white bars—
highly metastatic BLM melanoma cells), are mean ± SEM from three
to six independent experiments in quadruplicate cultures analyzed in
duplicates. *, P < 0.05, **, P < 0.001 vs. 1-g control groups
Fig. 2 Simulated microgravity down-regulates mRNA expression of
GC-cGMP signaling components in non-metastatic human melanoma
cells. a Relative mRNA expression of eNOS/iNOS, sGC-α1/sGC-
β1, GC-A/GC-B, MRP4/MRP5, PDE5A, PKGI, and TYR in non-
metastatic 1F6 melanoma cells. b Relative mRNA expression of
eNOS/iNOS, GC-A/GC-B, and MRP4/MRP5 in 1F6 melanoma cells
transfected with siRNA against the sGC-β1 subunit or with scram-
bled siRNA. The investigated human melanoma cells were exposed
for 24 h to simulated microgravity (g-forces range ≤0.012 g) using a
fast-rotating 2-D clinostat or to 1 g. The relative mRNA expression of
the investigated genes was measured by quantitative real-time RT-PCR
analysis using calibrator-normalized and efficiency-corrected relative
quantification method (LightCycler®, Roche, Mannheim, Germany).
Data are means ± SEM from three to five independent experiments of
sixplicate cultures and pooled fractions of two cultures of each exper-
iment were analyzed in duplicates. *, P < 0.05, **, P < 0.001 vs. 1-g
control groups
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GC-A, GC-B, MRP4, and MRP5 in 1F6 cells transfected
with siRNA against sGC-β1 with the respective lev-
els in parental cells (Fig. 2b). The results show that
the transfection induced a partial reduction in the simu-
lated microgravity-induced down-regulation of the relative
mRNA expression (≤0.012 g /1 g ratio) for eNOS (0.79
± 0.01), MRP4 (0.86 ± 0.06) and MRP5 (0.85 ± 0.7) in
transfected 1F6 melanoma cells (Fig. 2b) when compared to
parental cells (Fig. 2a).
The most potent simulated microgravity-induced down-
regulation of the investigated relative mRNA values
(≤0.012 g /1 g ratio) was found in highly metastatic BLM
melanoma cells for iNOS (0.69 ± 0.04), GC-A (0.55
± 009) and GC-B (0.53 ± 0.03) (Fig. 3a). The mRNA
levels of expression presented for GC-B and GC-A are
similar to results of our published report (Ivanova et al.
2011). Further, the MRP5 mRNA expression is significantly
down-regulated in simulated microgravity compared to 1 g,
whereas the mRNA level of MRP4 is not affected (Fig. 3a).
We additionally determined the effects of simulated
microgravity on the mRNA expression of the PDE5A,
which is controlling the cytosolic cGMP levels, as well
as the mRNA expression of PKGI, which phosphorylates
serine and threonine residues in many cellular proteins. As
shown in Fig. 2a for non-metastatic 1F6 and in Fig. 3a
for highly metastatic BLM melanoma cells, we observed
a significant reduction of PKGI only in highly metastatic
BLM melanoma cells, but no changes of the PDE5A
expression in both clinorotated cells when compared to 1-g
control levels.
Finally, as the most potent simulated microgravity-
induced down-regulation of the investigated mRNA expres-
sion was found for the cancer-related genes iNOS, GC-A
and GC-B when compared to 1 g, we measured additionally
the protein levels of iNOS, GC-A and GC-B using West-
ern blot analysis. The protein levels of GC-A (∼120 kDa),
GC-B (∼140 kDa) and iNOS (∼130 kDa) in BLM human
melanoma cells reflect the patterns seen with the respective
mRNA levels (Fig. 3b).
SimulatedMicrogravity Induces Anti-Migratory
Effects in Highly Metastatic BLMMelanoma Cells
As expression of the GC-A and GC-B in melanoma
cells appears to correlate to metastatic potential (Ivanova
et al. 2001; Kong et al. 2008) and we previously reported
down-regulation of GC-A and GC-B expression in highly
metastatic BLMmelanoma cells after exposure to simulated
microgravity in the range of ≤0.012 g for the time
period of both 6 h and 24 h (Ivanova et al. 2011), we
applied a scratch assay to study the effects of simulated
microgravity on the migration of the BLM melanoma cells.
Fig. 3 Expression of e/iNOS-GC-cGMP-MRP4/MRP5 signaling
components in highly metastatic human melanoma cells. a Rela-
tive mRNA expression of eNOS/iNOS, GC-A/GC-B, MRP4/MRP5,
PDE5A, and PKGI in highly metastatic BLM melanoma cells. The
investigated human melanoma cells were exposed for 24 h to sim-
ulated microgravity (g-forces range ≤0.012 g) using a fast-rotating
2-D clinostat or to 1 g. The relative mRNA expression of the investi-
gated genes was measured by quantitative real-time RT-PCR analysis
using calibrator-normalized and efficiency-corrected relative quantifi-
cation method (LightCycler®, Roche, Mannheim, Germany). Data are
means ± SEM from three to five independent experiments of sixpli-
cate cultures and pooled fractions of two cultures of each experiment
were analyzed in duplicates. b Representative Western blots of the pro-
tein expression of GC-A/GC-B (membrane fractions), iNOS (cytosolic
fraction), and β-actin as a loading control in highly metastatic BLM
melanoma cells. The results were confirmed in three independent
experiments using sixplicate cultures and pooled protein of each exper-
iment was analyzed. *, P < 0.05, **, P < 0.001 vs. 1-g control
groups
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In addition, results of a live cell imaging by means of a
fast-rotating clinostat microscope (60 rpm) indicated that
highly metastatic melanoma BLM cells are able to detach,
migrate and attach again without any sign of apoptosis
during clinorotation for 6 h (Ivanova et al. 2011).
Here, we present results for effects of simulated
microgravity (≤0.012 g) on the BLM melanoma cell
migration at 6 h, 12 h and 24 h after scratching in
comparison to 1-g controls. Figure 4a shows the quantitative
evaluation of the cell-free wound areas at the investigated
time points reflected by percentage of the initial scratch area
at t = 0 h (100%). In addition, the variation in the initial
scratches of the sample was of approximately 5.1%. In the
scratch assay, simulated microgravity (≤0.012 g) reduced
significantly the number of the cells in the wounded region
of the BLM melanoma cell monolayers at 6 h and 12 h after
scratching compared to the corresponding 1-g controls (e.g.,
1 g for 6 h: 57.7% ± 4.0%, clinorotation for 6 h: 69.2%
± 3.1%; 1 g for 12 h: 32.6% ± 2.4%, clinorotation for
12 h: 38.5% ± 2.7%). Finally, the wound areas of the 1-g
control BLM melanoma cell monolayers were completely
closed after incubation for 24 h at 37 ◦C, whereas in
the clinorotated cell monolayers approximately 5% of the
wound area remained. In addition, representative images
of the wound areas of BLM melanoma cell monolayers
immediately (0 h) as well as of the wound areas of cell
monolayers exposed to simulated microgravity (≤0.012 g)
and of the wound areas under control conditions (1 g)
at 6 h after scratching are shown in Fig. 4b. The wound
closures of the clinorotated for 6 h highly metastatic
BLM melanoma cell monolayers converged more slowly
in comparison to the wound closures of the respective 1-
g control cell monolayers, indicating a reduction of the
migratory potential of the cells in simulated microgravity.
Discussion
In previous studies, we have demonstrated differential
expression of functional guanylyl cyclase isoforms in
human melanocyte and melanoma cells as well as an
involvement of cGMP in the response of melanocytes to
gravity changes. The present results indicate that hyper-
gravity and simulated microgravity inversely modulate the
expression of GC-cGMP signaling components in human
melanoma cells. The most important finding is that sim-
ulated microgravity down-regulates the expression of the
cancer-related genes iNOS, GC-A and GC-B in highly
metastatic melanoma cell as well as motility, suggesting a
reduction of the melanoma aggressiveness in microgravity
condition.
In this study, we used human melanoma cell lines with
different metastatic potential and pigmentation to investi-
gate the effects of altered gravity on the expression of GC-
cGMP signaling components. In pigmented 1F6 melanoma
cells, hypergravity (5 g for 24 h) induces an increase in the
mRNA expression of eNOS and MRP4/MRP5, but there are
no apparent changes in the mRNA expression of GC-A/GC-B
when compared to 1-g controls. Thus, eNOS-cGMP signaling
seems to be involved in the previously reported hypergravity-
induced and MRP4/MRP5-dependent cGMP efflux in
melanoma cells expressing functional sGC (Ivanova et al.
Fig. 4 Simulated microgravity reduces motility of highly metastatic
melanoma cells in vitro. a and b Analysis of highly metastatic human
BLM melanoma cell migration by a scratch assay. Confluent mono-
layers of cells were wounded (0 h) and then exposed for 6 h, 12 h or
24 h to simulated microgravity (simulated μg; g-forces range ≤0.012
g) or under control conditions (1 g). a Quantitative evaluation of cell
migration at the investigated time points reflected in percentage of the
initial scratch area at t = 0 h (100%). Data in bar graphs are mean
± SEM from three to four independent experiments in triplicate cul-
tures (*, P < 0.05 vs. 1-g control groups). b Representative images of
BLMmelanoma cell monolayers immediately (t = 0 h) as well as after
exposure for 6 h to simulated μg or under 1 g-control conditions after
initiating a scratch wounds on confluent slide culture flasks
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2004). Moreover, hypergravity was unable to induce
changes in the mRNA expression of eNOS, MRP4/MRP5
in 1F6 melanoma cells transfected with siRNA against the
sGC-β1 subunit, indicating that a cytosolic-localized pool
of elevated cGMP is targeted by hypergravity. As we did
not observe previously marked changes in the morphol-
ogy and proliferation in the accelerated cells in comparison
to 1-g controls (Ivanova et al. 2004), it is suggested that
the reduction of intracellular cGMP concentration due to
enhanced expression of MRP4/MRP5 as cGMP exporter
may play a role in the adaptation of melanoma cells to
hypergravity. However, future in vivo studies under hyper-
gravity conditions should contribute to clarify whether the
extracellular cGMP has a signaling function in adjacent
cells or processes in the tumor microenvironment. In addi-
tion, the finding that hypergravity does not alter the mRNA
expression of e/iNOS, GC-A/GC-B and MRP4/MRP5 in
metastatic melanoma cells compared to 1-g controls sup-
port our previous observation that melanoma cells, which
do not express functional sGC, are apparently insensitive to
hypergravity effects (Ivanova et al. 2004).
In a previous study we also reported a relationship
between hypergravity-induced increase in melanin content
and increases in both intra- and extracellular levels of
cyclic adenosine-3′,5′-monophosphate (cAMP) (Ivanova
et al. 2004), a well-known modulator of melanogenesis
in melanocytes (Park and Gilchrest 1999). Interestingly,
our current data demonstrate that the hypergravity-induced
increase in the mRNA expression of tyrosinase in pigmented
1F6 melanoma cells is partly reversed in 1F6 cells
transfected with siRNA against sGC-β1 subunit, suggesting
a partial role of cGMP signaling in the hypergravity-
induced pigmentation. In addition, a role of sGC-cGMP
signaling was shown in the UVB-generated NO as one
of the melanogens acting via enhancement of tyrosinase
gene expression as a primary mechanism of NO-induced
melanogenesis (Sasaki et al. 2000). Thus, hypergravity
can be considered as another stimulus that is able to
enhance at least partly melanin content in pigmented
human melanocytic cells expressing NO-sensitive sGC.
This finding could be of importance for humans being
exposed to hypergravity environment.
In contrast to the hypergravity effects, simulatedmicrograv-
ity was found to down-regulate the eNOS-sGC-MRP4/MRP5
signaling in pigmented 1F6 melanoma cells. Silencing of
the sGC-β1 subunit expression in 1F6 melanoma cells
reversed slightly the simulated microgravity-induced
down-regulation in the mRNA expression of eNOS and
MRP4/MRP5, indicating that down-regulation of MRP4
and MRP5 expression is only partly dependent on the
presence of NO-sensitive sGC. Regarding the simulated
microgravity-induced down-regulation of NO-sensitive
sGC expression in non-metastatic melanoma cells, it can
be suggested that this type of melanoma cells may undergo
malignant transformation during long-term-exposure to
microgravity environment, as suppression of sGC expres-
sion and activities have been proposed as a biomarker for
tumor aggressiveness (Mujoo et al. 2010).
In the present study, we further demonstrate down-
regulation of iNOS expression in the investigated metastatic
melanoma cells under simulated microgravity condition.
As iNOS expression is absent in benign nevi and present
in invasive melanoma (Massi et al. 2001), and the levels
of expression correlates strongly with poor clinical out-
come (Ekmekcioglu et al. 2000, 2006), the down-regulation
of iNOS mRNA expressions in highly metastatic BLM
melanoma cells may also contribute to the reduction of
melanoma aggressiveness in the microgravity environment.
Importantly, as shown in our previous studies (Ivanova
et al. 2011) and verified here additionally on protein
level, simulated microgravity induces down-regulation of
the expression of both ANP-responsible GC-A and CNP-
responsible GC-B in the investigated metastatic melanoma
cells in comparison to 1-g controls. Moreover, our cur-
rent data indicate a reduction in the motility of clinorotated
highly metastatic BLM melanoma cells in comparison to
1-g control cells, which is in agreement with a reported
reduction of migration for human lung adenocarcinoma cell
line (Chang et al. 2013) as well as for human glioblas-
toma U87 cells during clinorotation (Shi et al. 2015).
In addition, very recent report shows that the ability of
fibroblasts to migrate was significantly impaired at modeled
microgravity conditions using a Rotary cell culture system
(Cialdai et al. 2017). However, whether the reduction of the
migratory potential of BLM melanoma cells depends only
on the reduction in GC-A and GC-B expression or other
contributing factors remains to be investigated.
Interestingly, we further found down-regulation of the
expression of PKGI and MRP5, but not for MRP4
in these cells. In addition, it has been documented
that CNP, which can be secreted by endothelial cell,
particularly under inflammatory conditions (Potter et al.
2006), enhances the activity of PKGI in melanoma cells
by increasing the intracellular levels of cGMP (Dhayade
et al. 2016). Activation of this cGMP pathway promotes
melanoma cell growth and migration in both in vitro
and in vivo in preclinical melanoma model (Dhayade
et al. 2016). Expression analysis of a panel of human
melanoma cells and tumor sections of human melanoma
patients further indicated that PGKI is probably not the
only effector of cGMP in melanoma cells that may
reflect the well-known heterogeneity of melanoma cells
(Dhayade et al. 2016). Moreover, it is well known that the
cell microenvironment in vivo strongly affects malignant
transformation and metastatic behavior of cancer cells.
In addition, cGMP signaling may also affect various
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processes in the tumor microenvironment such as blood
flow, angiogenesis, inflammation, and immune response.
However, future in vivo studies are needed to elucidate the
potential role and the mechanism of cGMP signaling in
melanocyte transformation in real microgravity.
In conclusion, the results of the present in vitro study
demonstrate differential effects of altered gravity on the
expression of genes involved in guanylyl cyclase-cGMP
signaling in human melanoma cells. Whereas hypergrav-
ity induces an up-regulation of eNOS-sGC-cGMP-MRP4/5
signaling pathway in non-metastatic melanoma cells, in
highly metastatic cells both e/iNOS and GC-A/GC-B-
cGMP signaling pathways remained insensitive to hyper-
gravity when compared to 1 g. The present data further sug-
gest that hypergravity can be considered as a melanogenic
stimulus in pigmented melanoma cells expressing NO-
sensitive sGC, as it is able to induce a sGC-dependent
increase in tyrosinase expression in these cells. Most impor-
tantly, simulated microgravity induces down-regulation in
the expression of cancer-related genes iNOS and GC-A/GC-
B in highly metastatic human melanoma cells, but also
down-regulation of the NO-sensitive sGC expression in
non-metastatic melanoma cells, whose expression and activ-
ity have been inversely related to tumor aggressiveness. The
results suggest that future studies in real microgravity can
benefit from considering GC-cGMP signaling as a possi-
ble factor for melanocyte transformation as well as by the
adaptation of medication regimes in future spaceflights.
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